Aqemia
aqemia.com
Actively hiring
AI for Science
Drug Discovery
As featured in
View 1 job
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$38M
1 round on record
Latest round
$38M
Venture round · Dec 2024 · 22 mo ago
Team
50–99
French register · Dec 2023
Hiring now
3
+2 posted in 30 days
Backers
1
Elaia
The money's age
Due for its next round
22 months since the last round · and hiring
Momentum
27/100
hiring for its size
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 10, 2024
Raised a round Venture round $38M · TechCrunch
Sep 22, 2021
Increased its share capital $19k · BODACC
Dec 3, 2019
Increased its share capital $15k · BODACC
Jun 12, 2019
Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2024 | $38M | — | TechCrunch |
Registers and programsofficial lists and records that name the company
| Legal entity | AQEMIA | recherche-entreprises |
| Registered | 12 Jun 2019 |
Founders and leadersfrom filings, registers and the company's site
Emmanuelle Martiano Rolland RollandDirecteur Généralcompany register
Backed byfrom the funds' portfolios and accelerator catalogs
Elaia Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Molecule.one is a Warsaw deep technology company founded in 2018 that applies machine learning to chemical synthesis. Its models predict…
Protein engineering AI, built for scientists. Leverage AI to generate protein candidates and improve their properties. More breakthroughs…
Kvantify is a Danish quantum software company founded in 2022 and based in Copenhagen. It develops quantum and high-performance computing…
PharmEnable combines medicinal chemistry expertise with machine learning to find drug candidates for challenging protein targets. Founded…
Human iPSC-derived hepatocytes, organoids and AI-powered Cell Painting for predictive drug discovery. Trusted by AstraZeneca, Sanofi, Deep…
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
Overview
Aqemia is a Paris company founded in 2019 that designs drug candidates with quantum-inspired statistical physics and deep learning. Its platform predicts binding affinity without experimental training data, allowing very large virtual screening campaigns. The company runs its own therapeutic programmes and partners with pharmaceutical groups such as Sanofi.
News
Aqemia and Sanofi Expand Their Research Collaboration
PARIS & LONDON, July 17, 2026--Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical co
Read more
Report
Aqemia and Sanofi Expand Their Research Collaboration
PARIS & LONDON, July 17, 2026--Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical co
Read more
Report
Report
Report
Aqemia: $7.4 Million Grant Secured To Advance Epitranscriptomics Programs
Aqemia announced it is broadening and accelerating its computational platform to target RNAs using its physics-enabled generative AI engine. Creating on successes in epitranscriptomics, Aqemia looks to develop novel small-molecule drugs against this emerg
Read more
Report
AQEMIA: Drug Discovery Pipeline Company Raises $38 Million
AQEMIA, a biotechnology company that teaches atomic-scale physics to a generative AI (GenAI) for inventing new medicines, announced two significant milestones: $100 million in total funding and the beginning of a global expansion, starting with London (Un
Read more
Report
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI
Aqemia, a French startup that's meshing "quantum-inspired physics" with machine learning to find new drugs, has raised $38M.
Read more
Report
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI
Aqemia, a French startup that
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Aqemia over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
2
Stack modernity
85/100
Practices & domains
Machine Learning
Sign in to see how your skills match this stack
Sign In
People
Emmanuelle Martiano Rolland Rolland
Directeur Général
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
70/100
Growing
Open positions
3
2 opened / 2 closed in 30 days
Median time-to-fill
44 days
faster than 30% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Science & Research
33% ▼
AI/ML
17% ▲
Leadership
17% ▲
HR
17% ▼
Legal
17% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Paris
Paris
France
HQ
3 open roles 5 posted in 90 days 33% engineering 50-200 est. staff
hires for Leadership, Legal, Science & Research
Earlier presence
London, United Kingdom
Jobs
≈ $64k – $117k per year (Estimated) • Hybrid • Full-Time • Paris
Machine Learning
Apply
Financials
Total raised
$38M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $38M | Details |